Cellibre key facts
as of Oct 2026- Operator of a cellular agriculture company intended to develop sustainable biological products.
- Cellibre is valued at approximately $52.6M as of Oct 2026, set at its later-stage round, Oct 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $30.1M across 3 recorded rounds; the latest was Early Stage VC ($6.7M) in Sep 2024.
- Notable investors include Alumni Ventures, Liquid 2 Ventures, Prithvi Ventures, Alexander Amand, Arcview Ventures — 20 tracked in total.
- 1 investment vehicle was formed to buy Cellibre shares in the last 12 months, reporting $55K sold to 8 investors, per SEC Form D filings.
- Cellibre has filed 3 Form Ds with the SEC since 2019, most recently Oct 2024 ($6.7M sold to 31 investors).
- Status: Privately Held (backing).
Valued at $52.6M at its later-stage round, Oct 2024. Nothing has traded since.
- ·The complete investor list: 20 names
- ·Watch Cellibre: the Monday email on marks, rounds and moves
Cellibre funding rounds
3 roundsVehicles formed to buy Cellibre shares
secondary demand · SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy Cellibre shares, reporting $55K sold to 8 investors. Most recent filing Oct 2025.
Membership and data by Private Market View
Who backs Cellibre
20+Cellibre valuation
Cellibre was valued at $52.6 million at its later-stage round in Oct 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Cellibre raised?
Cellibre has raised $30.1 million across 3 recorded rounds since 2019. The largest was a $9.9 million early-stage round in Aug 2021; the most recent was a $6.7 million early-stage round in Sep 2024.
Cellibre has filed 3 Form Ds with the SEC since 2019, most recently in Oct 2024 ($6.7 million sold to 31 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Cellibre shares, reporting $55,000 sold to 8 investors, per SEC Form D filings (most recent Oct 2025).
Cellibre investors
20 investors are on record for Cellibre, including Alumni Ventures, Liquid 2 Ventures, Prithvi Ventures and Alexander Amand. The early-stage round in Sep 2024 drew 31 investors.
About Cellibre
Operator of a cellular agriculture company intended to develop sustainable biological products. The company employs an organism-agnostic approach, precision fermentation, AI-driven enzyme and protein engineering, and high-throughput strain and bioprocess optimization, enabling pharmaceutical, functional health, beauty, and nutraceutical companies to access scalable, lower-cost, higher-quality ingredients while reducing reliance on agriculture and strengthening supply chain resilience.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2017
- Employees
- 29
- Website
- cellibre.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.